A detailed history of Perpetual LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Perpetual LTD holds 25,621 shares of BMRN stock, worth $1.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,621
Previous 4,874 425.67%
Holding current value
$1.4 Million
Previous $264 Million 476.82%
% of portfolio
0.02%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 20, 2026

BUY
$51.46 - $55.61 $1.07 Million - $1.15 Million
20,747 Added 425.67%
25,621 $1.52 Billion
Q3 2025

Oct 10, 2025

SELL
$52.62 - $61.93 $479,157 - $563,934
-9,106 Reduced 65.14%
4,874 $264 Million
Q2 2025

Jul 11, 2025

BUY
$54.08 - $68.32 $756,038 - $955,113
13,980 New
13,980 $768 Million
Q4 2024

Jan 17, 2025

BUY
$61.93 - $70.49 $216,816 - $246,785
3,501 New
3,501 $230 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Perpetual LTD Portfolio

Follow Perpetual LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.